News
AstraZeneca proceeds for construction of full cycle facility for production of innovative drug formulations
AstraZeneca proceeds for second construction phase of its own high-tech plant at Vorsino Industrial Park, Kaluga Region, which will include full cycle pharmaceutical production facility. Total volume of investments in the construction of the plant will amount to approximately $187 mln, from which more than $100 mln will be allocated for the second phase.
Initially the launch of construction of the full cycle facility was scheduled for 2014, but dynamic project development and also openness and involvement of the regional administration enabled the company to proceed for the second phase ahead of schedule. The launch of production of solid drug formulations is expected for 2016, and the full cycle production capacity will be 500 million tablets per year.
About thirty innovative AstraZeneca drug formulations will be manufactured at the plant to treat diseases in such therapeutic areas as oncology, cardiology, gastroenterology, psychiatry and pulmonology.
16.09.2013
Share in
Other news
Investment digest
Printed products
Production placement application
Establishment of industrial parks with high quality sites with all relevant utilities for new plants construction ensures well-balanced distribution of industrial facilities throughout the region with due consideration of transport, utilities and social infrastructure development and future labor resources development.
If you are interested in placement of a production facility at an investment site, please fill in the online application form.
Thank you!
You successfully subscribed to news digest
Thank you!
Your message has been sent.
error
Error!